Related Experiment Video
Updated: Feb 24, 2026

High Content Screening in Neurodegenerative Diseases
Published on: January 6, 2012
An integrative system biology approach to unravel potential drug candidates for multiple age related disorders
Isha Srivastava1, Pooja Khurana1, Mohini Yadav1
1Department of Biotechnology, Delhi Technological University, Shahbad Daulatpur, Main Bawana Road, Delhi 110042, India.
Abstract:
Aging, though an inevitable part of life, is becoming a worldwide social and economic problem. Healthy aging is usually marked by low probability of age related disorders. Good therapeutic approaches are still in need to cure age related disorders. Occurrence of more than one ARD in an individual, expresses the need of discovery of such target proteins, which can affect multiple ARDs. Advanced scientific and medical research technologies throughout last three decades have arrived to the point where lots of key molecular determinants affect human disorders can be examined thoroughly. In this study, we designed and executed an approach to prioritize drugs that may target multiple age related disorders. Our methodology, focused on the analysis of biological pathways and protein protein interaction networks that may contribute to the pharmacology of age related disorders, included various steps such as retrieval and analysis of data, protein-protein interaction network analysis, and statistical and comparative analysis of topological coefficients, pathway, and functional enrichment analysis, and identification of drug-target proteins. We assume that the identified molecular determinants may be prioritized for further screening as novel drug targets to cure multiple ARDs. Based on the analysis, an online tool named as 'ARDnet' has been developed to construct and demonstrate ARD interactions at the level of PPI, ARDs and ARDs protein interaction, ARDs pathway interaction and drug-target interaction. The tool is freely made available at http://genomeinformatics.dtu.ac.in/ARDNet/Index.html.
Insights
This study identifies key molecular targets to treat multiple age-related disorders (ARDs). An online tool, ARDnet, aids in discovering drug targets for healthier aging and combating age-related diseases.
Area of Science:
- Gerontology
- Computational Biology
- Pharmacology
Background:
- Aging is a global challenge with increasing social and economic impact.
- Healthy aging is characterized by a low incidence of age-related disorders (ARDs).
- Current therapeutics often target single ARDs, highlighting the need for treatments addressing multiple conditions simultaneously.
Purpose of the Study:
- To develop a computational approach for prioritizing drugs targeting multiple ARDs.
- To identify key molecular determinants and drug-target proteins relevant to various ARDs.
- To create a publicly accessible tool for exploring ARD-related interactions.
Main Methods:
- Analysis of biological pathways and protein-protein interaction (PPI) networks.
- Data retrieval, network analysis, and statistical evaluation of topological coefficients.
- Pathway and functional enrichment analysis for identifying drug-target proteins.
Main Results:
- Identification of molecular determinants with the potential to target multiple ARDs.
- Development of the ARDnet online tool, visualizing PPI, ARD, pathway, and drug-target interactions.
- The ARDnet tool is available at http://genomeinformatics.dtu.ac.in/ARDNet/Index.html.
Conclusions:
- The identified molecular targets offer promising avenues for novel drug development against multiple ARDs.
- The ARDnet tool facilitates research into the complex molecular underpinnings of aging and associated disorders.
- This approach supports the development of more effective therapeutic strategies for promoting healthy aging.
More Related Videos
09:47Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
Published on: December 15, 2023
11:44Cellular Membrane Affinity Chromatography Columns to Identify Specialized Plant Metabolites Interacting with Immobilized Tropomyosin Kinase Receptor B
Published on: January 19, 2022
Related Concept Videos
Pharmacodynamics in Geriatric Patients: Effects of Age
Drug Dosing: Geriatric Patients
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
Pharmacogenomics: Identification of New Drug Targets
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution